A phase II trial of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer.

被引：0
|
作者：
Lu, YS
Kuo, SH
Su, WP
Yang, CH
Hsu, C
Yang, TL
Huang, CS
机构：
[1] Natl Taiwan Univ Hosp, Taipei, Taiwan
[2] Mackay Mem Hosp, Taipei, Taiwan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：93S / 93S
页数：1
相关论文
共 50 条
  • [41] Epirubicin and docetaxel as neoadjuvant treatment of locally advanced breast cancer: a phase II study
    Lombardi, D.
    Scalone, S.
    Crivellari, D.
    La Mura, N.
    Miolo, G.
    Murrone, A.
    Perin, T.
    Coran, F.
    Candiani, E.
    Massarut, S.
    Veronesi, A.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S229 - S229
  • [42] Cisplatin and vinorelbine as neoadjuvant chemotherapy in locally advanced cervical cancer: A Phase II study
    di Vagno, G
    Cormio, G
    Pignata, S
    Scambia, G
    Di Stefano, MG
    Tambaro, R
    Trerotoli, P
    Serio, G
    Garganese, G
    Selvaggi, L
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2003, 13 (03) : 308 - 312
  • [43] Epirubicin and docetaxel as neoadjuvant treatment of locally advanced breast cancer: a phase II study
    Lombardi, Davide
    Scalone, Simona
    Crivellari, Diana
    Magri, Maria Donatella
    La Mura, Nicoletta
    Miolo, GianMaria
    Murrone, Antonio
    Perin, Tiziana
    Coran, Francesco
    Candiani, Ezio
    Massarut, Samuele
    Veronesi, Andrea
    [J]. TUMORI JOURNAL, 2010, 96 (02): : 229 - 233
  • [44] Neoadjuvant chemotherapy with cisplatin and gemcitabine followed by chemoradiation with cisplatin in locally advanced cervical cancer: A phase II, prospective, randomized, trial
    Silva, Samantha
    Bonadio, Renata R. C. Colombo
    Gabrielli, Flavia
    Aranha, Andrea Souza
    Genta, Maria Luiza
    Miranda, Vanessa Costa
    Freitas, Daniela
    Filho, Elias Abdo
    Ferreira, Patricia Alves De Oliveira
    Kalil, Karime
    Scaranti, Mariana
    Estevez-Diz, Maria Del Pilar
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [45] Predicitve factors for neoadjuvant chemotherapy in locally advanced breast cancer.
    Perez, MA
    Ruiz, J
    Astudillo, H
    Silva, M
    Silva, J
    Pluma, MA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 91S - 91S
  • [46] Neoadjuvant Docetaxel, Capecitabine and Cisplatin (DXP) in Patients with Unresectable Locally Advanced or Metastatic Gastric Cancer
    Sun Jin Sym
    Heung Moon Chang
    Min-Hee Ryu
    Jae-Lyun Lee
    Tae Won Kim
    Jeong Hwan Yook
    Sung Tae Oh
    Byung Sik Kim
    Yoon-Koo Kang
    [J]. Annals of Surgical Oncology, 2010, 17 : 1024 - 1032
  • [47] Neoadjuvant Docetaxel, Capecitabine and Cisplatin (DXP) in Patients with Unresectable Locally Advanced or Metastatic Gastric Cancer
    Sym, Sun Jin
    Chang, Heung Moon
    Ryu, Min-Hee
    Lee, Jae-Lyun
    Kim, Tae Won
    Yook, Jeong Hwan
    Oh, Sung Tae
    Kim, Byung Sik
    Kang, Yoon-Koo
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (04) : 1024 - 1032
  • [48] Chemotherapy with cisplatin, epirubicin and docetaxel in transitional cell urothelial cancer. Phase II trial
    Pectasides, D
    Visvikis, A
    Aspropotamitis, A
    Halikia, A
    Karvounis, N
    Dimitriadis, M
    Athanassiou, A
    [J]. EUROPEAN JOURNAL OF CANCER, 2000, 36 (01) : 74 - 79
  • [49] A phase II study of capecitabine and weekly docetaxel combination chemotherapy in patients with metastatic breast cancer.
    Puglisi, F
    Scalone, S
    Minisini, AM
    Mansutti, M
    Crivellari, D
    Buonadonna, A
    Zanetti, M
    Ermacora, P
    Piga, A
    Veronesi, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 78S - 78S
  • [50] Neoadjuvant cisplatin and doxorubicin in locally advanced triple negative breast cancer.
    Mateen, Abdul
    Adil, Allah Rakha
    Maken, Rab Nawaz
    Hashmi, Quratul Ain
    Abdullah, Famya
    Duraishi, Arif Moin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345